Eukaryotic ribosome and translation initiation machinery (80S/eIF complex)

The eukaryotic ribosome and translation initiation machinery constitute the fundamental apparatus for protein synthesis in eukaryotic cells. The 80S ribosome, composed of the 40S and 60S subunits, works in concert with a diverse set of eukaryotic translation initiation factors (eIFs) to decode mRNA into functional polypeptides [StatPearls, 2023]. This machinery is frequently dysregulated in various diseases, particularly cancer, where increased translation of oncogenic mRNAs such as MYC and cyclin D1 drives tumor progression and survival [Nature Reviews Cancer, 2019]. Pharmacological targeting of this system involves small molecules that inhibit specific components, such as the eIF4F complex or the ribosomal peptidyl transferase center [PubMed, 2021]. For instance, omacetaxine mepesuccinate inhibits the 60S subunit to treat chronic myeloid leukemia, while newer agents like zotatifin target the eIF4A helicase [ClinicalTrials.gov, 2024]. Viruses also exploit this machinery to prioritize the translation of viral proteins over host proteins, making it a target for antiviral therapy [Frontiers in Microbiology, 2021]. While effective in suppressing protein synthesis in rapidly dividing cells, these therapies often face challenges related to systemic toxicity and a narrow therapeutic index due to the essential nature of translation in all healthy tissues [Journal of Biological Chemistry, 2020]. Research continues to focus on identifying specific initiation factors that are selectively required by cancer cells to improve therapeutic windows.

Other names

80S ribosomeTranslation initiation complexeIF complexProtein synthesis machineryeIF4F complex

Inhibition of the peptidyl transferase center (PTC) within the 60S ribosomal subunit, inhibition of the eIF4A RNA helicase activity, disruption of the eIF4F complex assembly, or blocking the recruitment of the 40S subunit to the mRNA 5' cap.